Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 403-080-9 | CAS number: 92484-48-5 BENZTRIAZOL UV ABSORBER BUK 4499; BUK 4499; UV ABSORBER BUK 4499
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Key value for chemical safety assessment
Skin sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not sensitising)
- Additional information:
There are two skin maximisation tests available that evaluate the contact allergenic potency of sodium 3-(2H-benzotriazol-2-yl)-5-sec-butyl-4-hydroxybenzenesulfonate. The study with the higher dose level at the challenge treatment (25 % test article in physiological saline) was used as key study.
Maximization test (Key study):
This test was based on the OECD Guideline No. 406 (Skin Sensitisation) and the EU method B.6 (Skin Sensitisation). The intradermal induction of sensitization was performed with a 5 % dilution of the test article in physiological saline and in an emulsion of Freund's Complete Adjuvant (FCA)/ physiological saline. The epidermal induction of sensitization was conducted under occlusion with the test article at 25 % in physiological saline. Two weeks after the epidermal induction application the challenge was completed by epidermal application of the test article at 25 % in physiological saline under occlusive dressing. A second challenge was performed two weeks after the first challenge with concentration of 25 %. The method was equal to that described for the first challenge with the exception that the flanks of all the guinea-pigs were changed. The animals of the control group were induced with FCA/physiological saline and challenged similarly to those of the test group. Cutaneous reactions, i.e. erythema and oedema formation were evaluated at 24 and 48 hours after removal of the dressing. At the vehicle control no positive reactions were evident after the first and second challenge application. Positive reactions (edema, erythema, necroses) were observed after first challenge in 3 respectively 2 animals after 24- and 48 -hours reading. At the second challenge positive reactions were observed in 2 respectively 1 animal(s) after the 24- and 48 -hours reading. The test substance is, therefore, considered not to be a sensitizer when used under the described test conditions.
Maximization test (Supporting study):
This test was based on the OECD Guideline No. 406 (Skin Sensitisation) and the EU method B.6 (Skin Sensitisation). The intradermal induction of sensitization was performed with a 5 % dilution of the test article in bi-distilled water and in an emulsion of Freund's Complete Adjuvant (FCA)/ physiological saline. The epidermal induction of sensitization was conducted under occlusion with the test article at 50 % in bi-distilled water. Two weeks after the epidermal induction application the challenge was completed by epidermal application of the test article at 10 % in bi-distilled water under occlusive dressing. The animals of the control group were induced with bi-distilled water and FCA/physiological saline and challenged similarly to those of the test group. Cutaneous reactions, i.e. erythema and oedema formation were evaluated at 24 and 48 hours after removal of the dressing. None of the animals of the control and test group were observed with skin reactions after challenge treatment with a non-irritant test article concentration of 10 % in bidistilled water. Therefore, the test article applied at a concentration of 10 % in bi-distilled water is considered not to be a sensitizer when used under the described test conditions.
LLNA (Key study):
In addition, a local lymph node skin sensitisation test with the test substance sodium 3-(2H-benzotriazol-2-yl)-5-sec-butyl-4-hydroxybenzenesulfonate in mice was performed according to OECD Guideline 429. The assay determines the level of T lymphocyte proliferation in the lymph nodes draining the site of chemical application, by measuring the amount of radiolabelled thymidine incorporated into the dividing cells. The test substance was applied as 3%, 10% or 30% w/v preparations in propylene glycol. The application of the test substance at concentrations of 3%, 10% and 30% w/v in propylene glycol resulted in an isotope incorporation which was less than 3-fold at all three concentrations. Consequently, the test substance is not considered to be a potential skin sensitizer. In a positive control study, hexylcinnamaldehyde was shown to have the capacity to cause skin sensitisation when applied as 1%, 3% or 10% w/v preparations in acetone, confirming the validity of the protocol used for this study.
Photoallerginicity test (Supporting study)
In order to assess the photoallergenic potential of sodium 3-(2H-benzotriazol-2-yl)-5-sec-butyl-4-hydroxybenzenesulfonate a photoallergenicity test according to the CTFA Safety Testing Guidelines was carried out in 30 female (20 test and 10 control) Albino Dunkin Hartley guinea pigs. For the induction of sensitization 30 % of the test article in bi-distilled water was applied epicutaneously to a skin area of 8 cm2 (marked previously with 4 intradermal injections of Freund's Complete Adjuvant (FCA)/physiological saline). The test sites were then exposed to 1.8 J/cm2 UV-B and 10 J/cm2 UV-A irradiation. This procedure was repeated 4 times within 2 weeks of the induction phase. Control animals were intradermally treated with FCA/physiological saline only. Three weeks after beginning of the induction a challenge was carried out by treating the experimental animals (test and control) epicutaneously on both flanks with the test article at the concentrations of 15 %, 10 %, 5 % and 1 % (dilutions in bidistilled water). Treated sites were then either exposed to 10 J/cm2 UV-A irradiation (left flank) or remained unirradiated (right flank). Cutaneous reactions, i.e. erythema and oedema formation were evaluated at 24, 48 and 72 hours after the challenge exposure. No toxic symptoms were evident in the guinea pigs of the control or test group. It can be concluded that the test does not exhibit photollergenic potential in the guinea pig under the study conditions.
Migrated from Short description of key information:
Two maximisation tests in guinea pigs were performed to determine the contact allergenic potency of the test article. These tests were based on the OECD Guideline No. 406 (Skin Sensitisation) and the EU method B.5 (Skin Sensitisation). In the first test none of the control and test group animals were observed with skin reactions after challenge treatment with a non-irritant test article concentration of 10 % in bi-distilled water. In the other test 10% and 5% of the animals of the test group (25 % test article in physiological saline) showed skin reactions 24 and 48 hours after removing the dressings, respectively. The test substance is, therefore, considered not to be a sensitizer when used under the given test conditions.
Additionally, a Local Lymph Node Assay (LLNA) was performed according to the OECD Guideline 429. Also in this study the test substance is not considered to be a potential skin sensitizer.
One photosensitisation test (photoallergenicity) was performed according to the CTFA Safety Testing Guidelines. In this study the test substance did not exhibit a photoallergenic or phototoxic potential in the guinea pig under the given study conditions.
Justification for classification or non-classification
In the evaluation of all available information, the test substance is not classified with regard to sensitisation according to Directive 67/548/EEC (DSD) and to Regulation (EC) No 1272/2008 (CLP), respectively.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.